Dr. Francesco Pepe graduated with a degree in biotechnology from the University of Naples “Federico II”, Italy, in 2012, then he started as a trainer program at the University of Catania for the formation of novel figures able to analyze predictive biomarkers by using NGS technologies. He obtained a Ph.D. and Doctor Europaeus in Anatomic Pathology from the University of Naples “Federico II”, Italy, in 2018 under the direction of Professor Stefania Montagnani. He has worked as a post-doc student at the University of Naples, Italy, from 2018 to today. His research is focused on molecular oncology and immunotherapy in thoracic oncology and a pan-tumoral approach, using new-generation techniques in tissue and liquid biopsy samples, specifically in circulating free tumor DNA. He is the scientific support of the University of Naples Spin-off (Genedin), involved in the development of next-generation procedures for the detection and analysis of positive and negative biomarkers in the field of solid tumors.